AEON Biopharma names Paul Lee acting chief regulatory officer
AEON Biopharma designates former FDA neuroscience leader Paul Lee, M.D., Ph.D. as acting chief regulatory officer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.